InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,101.46
(
0.50%
)
Post# of 54376
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

KauaiPI

Send PM Follow Ignore
Followers 12
Posts 4191
Boards Moderated 0
Alias Born 01/10/2001

KauaiPI

Member Level

Re: KauaiPI post# 3380

Friday, 04/25/2003 10:15:20 AM

Friday, April 25, 2003 10:15:20 AM

Post# of 54376
DD on another APT like firm...MTMD

Profile - Microtek Medical Holdings (NasdaqNM:MTMD)
As of 23-Apr-2003

Upcoming Events May 6 Earnings Announcement
Location 512 Lehmberg Road
Columbus, MS 39702 Phone: (662) 327-1863
Email: webmaster@orex.com <mailto:webmaster@orex.com>
Employees (last reported count): 1,288

Company Website
·Home Page <http://www.orex.com>

Business Summary

Microtek Medical Holdings, Inc., formerly known as Isolyser Company, Inc., develops, manufactures and markets proprietary and other products and services for patient care, occupational safety and management of potentially infectious and hazardous waste, primarily for the domestic healthcare market. The Company has two primary operating units, Microtek Medical, Inc. (Microtek) and OREX Technologies International (OTI). Microtek manufactures and sells infection-control products, such as equipment drapes and patient drapes primarily for use in operating rooms and outpatient surgical centers. OTI seeks to develop and commercialize contamination-control materials and products coupled with engineered systems for the treatment and disposal of those materials.

Financial Summary
Microtek Medical Holdings, Inc. offers high-performance contamination-control materials and products coupled with engineered systems for the treatment and disposal of those materials and products. For the fiscal year ended 12/02, revenues rose 7% to $86.7 million. Net income rose 76% to $8.4 million. Revenues reflect the acquisition of the drapeand CleanOp product lines by Microtek. Earnings also reflect reductions in product development costs.

Ownership

· Insider and 5%+ Owners: -0%
· Institutional: 11% (11% of float)
(36 institutions)
· Net Inst. Buying: 142.0K shares (+3.09%)
(prior quarter to latest quarter)

Statistics at a Glance -- NasdaqNM:MTMD

As of 23-Apr-2003

Price and Volume

52-Week Low on 7-Oct-2002 $0.88
Recent Price $2.45 52-Week High on 25-Apr-2002 $3.40
Beta 1.73
Daily Volume (3-month avg) 54.6K
Daily Volume (10-day avg) 50.0K

as of 4-24-03;
Last Trade 3:57pm · 2.80 Change +0.35 (+14.29%)
Prev Cls 2.42 Open 2.48
Volume 249,350 Day's Range 2.46 - 2.84
Bid 2.67 Ask 2.83
P/E 12.10
Mkt Cap 117.8M Avg Vol 54,590
52-wk Range 0.88 - 3.55

Stock Performance

52-Week Change -25.5%
52-Week Change relative to S&P500 -11.4%

Share-Related Items

Market Capitalization $103.0M
Shares Outstanding 42.1M
Float 42.1M

Dividends & Splits

Annual Dividend none
Last Split: factor 2 on 3-Oct-1995

Per-Share Data

Book Value (mrq) $1.88
Earnings (ttm) $0.20
Earnings (mrq) $0.11
Sales (ttm) $2.02
Cash (mrq) $0.23

Valuation Ratios

Price/Book (mrq) 1.30
Price/Earnings (ttm) 12.44
Price/Sales (ttm) 1.21

Income Statements
Sales (ttm) $86.7M
EBITDA (ttm) $6.04M
Income available to common (ttm) $8.41M

Profitability

Profit Margin (ttm) 9.7%
Operating Margin (ttm) 6.4%

Fiscal Year

Fiscal Year Ends Dec 31
Most recent quarter 31-Dec-2002

Management Effectiveness

Return on Assets (ttm) 9.02%
Return on Equity (ttm) 11.48%

Financial Strength

Current Ratio (mrq) 5.98
Debt/Equity (mrq) 0.09
Total Cash (mrq) $9.82M

Short Interest As of 10-Mar-2003
Shares Short 659.0K
Percent of Float 1.6%
Shares Short (Prior Month) 658.0K Short Ratio 10.30
Daily Volume 64.0K

(attempted to updated but nothing more current than March's report!)
http://www.nasdaq.com/asp/quotes_full.asp?mode=&kind=shortint&symbol=intc&symbol=APT&...

Settlement ----Short ---Avg Daily ------Days to
--Date-------Interest---Share Volume--Cover
Mar. 14, 2003 659,390 ---63,863 --------10.33
Feb. 14, 2003 657,862 ---55,848 ---------11.78
Jan. 15, 2003 658,315 ---59,752 ----------11.02
Dec. 13, 2002 658,262 --104,403---------- 6.31
Nov. 15, 2002 810,532 --105,460 ----------7.69
Oct. 15, 2002 785,726 ---63,184 ----------12.44
Sep. 13, 2002 788,446 ---60,563 ----------13.02
Aug. 15, 2002 787,759 ---76,926 ----------10.24
Jul. 15, 2002 782,909 ---94,018 -------------8.33
Jun. 14, 2002 785,215 ---94,694 -------------8.29
May 15, 2002 805,196 --148,369 ------------5.43
Apr. 15, 2002 819,159 104,483 7.84


http://biz.yahoo.com/n/m/mtmd.html

(all times are US Eastern)

Thursday April 17, 2003

Microtek Medical Holdings Appoints KPMG as New Auditor
5:30 pm - PR Newswire

Thursday April 10, 2003

Microtek Medical Holdings Schedules Quarterly Earnings Release and Conference Call
9:01 am - PR Newswire

Thursday March 27, 2003

Annual Report with 10K for Microtek Medical Holdings
4:59 am - WILink

Monday February 24, 2003

Still More Upside Possible for Microtek
3:21 pm - RealCommentary from TheStreet.com

Wednesday February 19, 2003

Microtek Medical Holdings Reports Fourth Quarter and Full Year Results; Updates Revenue and Earnings Forecasts for FY 2003
8:48 am - PR Newswire

Q4 2002 MICROTEK MEDICAL HLDGS INC Earnings Release - Before Market Open
7:07 am - CCBN

Monday February 3, 2003

Microtek Medical Holdings Schedules Annual Earnings Release and Conference Call
8:32 am - PR Newswire

Tuesday December 24, 2002

Microtek Medical Is Set for a Happy New Year
6:59 am - RealCommentary from TheStreet.com

Monday November 11, 2002

Just a Matter of Time for Microtek
4:06 pm - RealCommentary from TheStreet.com


----ALSO note they have a share repurchase plan in place!----

During 2002, the Company utilized cash to finance the purchase of the drape product line of Gyrus ENT, to purchase property and equipment, to repay borrowings under its Credit Agreement, to make other scheduled debt repayments related to previous acquisitions of businesses, to make payments under equipment and capital leases and to repurchase shares of common stock under the Company’s stock repurchase program. During 2001, the Company utilized cash to fund working capital requirements, to finance the purchase of the drape and CleanOp product lines from Deka Medical and certain OREXTM processing equipment and related technology from MICROBasix LLC, to purchase other property and equipment, and to make scheduled debt repayments and payments under equipment and capital leases.

The $10.2 million provided by operating activities results principally from improved profitability and improved working capital management, particularly in the areas of accounts receivable and inventory management. Cash provided by operating activities was also impacted by increases in accounts payable and other accrued liabilities. Offsetting these increases in operating cash were increases in prepaid expenses and decreases in accrued compensation and other liabilities. The $2.5 million used in operating activities in 2001 results principally from the Company’s significant increases in inventories and accounts receivable resulting from increased sales. Also contributing to the use of cash in operating activities in 2001 were the decreases in accounts payable and the increases in prepaid expenses and other assets, which were partially offset by increases in accrued compensation and other liabilities. During 2002, cash used in investment activities consisted of acquisition costs of $4.1 million for the drape product line of Gyrus ENT and $1.5 million in capital property and equipment. Capital additions were primarily for building improvements, machinery and equipment, including computer equipment and software. During 2001, cash used in investing activities included acquisition costs of $11.6 million for the drape and CleanOp product lines from Deka Medical and $675,000 for certain OREX processing equipment and related technology from MICROBasix LLC. Also during 2001, the Company invested $1.1 million in capital property and equipment primarily associated with the Company’s expanded manufacturing operations in the Dominican Republic and investments to improve the Company’s internal management information systems. Cash used in financing activities in 2002 was $5.6 million, as compared to cash provided by financing activities in 2001 of $12.1 million. In 2002, the Company reduced its borrowings under its credit agreement by $5.3 million, repaid notes payable of approximately $664,000, and repurchased 369,000 shares of common stock for an aggregate amount of $678,000. Proceeds from the exercise of stock options and other issuances of common stock provided approximately $1.0 million in 2002.

=============
I took a position at market this a.m. prior to posting the above

best!
kp

"When you look at things differently,

things look different"
--Wayne Dyer--


Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up